ArcDia International

📍 Turku, Finland🗓 Founded 1993👥 20 employees💰 Last funded May 2025
ArcDia International Ltd provides the most complete solutions for acute infection diagnosis with our mariPOC rapid antigen tests. Our aim is to promote healthier living and improved health care processes for respiratory and gastrointestinal infections such as COVID-19, influenza, RSV, CDI and many more. The mariPOC platform is based on antigen detection using sandwich immunoassay principle and two-photon excited fluorescence assay technique. Thanks to the unique and proprietary technology, the platform provides automation, ease-of-use, multianalyte capability, cost-efficiency and high performance. With more than 10 years of experience in the in vitro diagnostics industry, ArcDia is an ISO 13485 certified company providing our mariPOC test system for global distribution. Our high-tech Nordic diagnostic solutions are made in Turku, in the heart of Finland’s health industry. Our product portfolio also includes mariAST (RUO), a solution for tackling antibiotic resistance by speeding up antimicrobial susceptibility testing and mariCloud, an on-line service for real-time epidemiological surveillance. ArcDia envisions a healthier planet by facilitating correct diagnosis and treatment, avoiding unnecessary antibiotics and enabling a faster recovery.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
1993
Founded
Investor geography1 country
Finland
2
Frequently asked questions
Who invested in ArcDia International?
ArcDia International has 2 investors on record on gritt.io.
When did ArcDia International last raise funding?
The most recent investment in ArcDia International recorded on gritt.io was in May 2025.
When was ArcDia International founded?
ArcDia International was founded in 1993.
What industry is ArcDia International in?
ArcDia International operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is ArcDia International based?
ArcDia International is headquartered in Turku, Finland.